Mary Elizabeth Hartnett,
MD
Languages Spoken: English
Mary Elizabeth Hartnett, MD, holds the Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences and is a Distinguished Professor at the University of Utah. She is an adjunct professor at the University of Utah departments of Neurobiology, Anatomy, and Pediatrics. Dr. Hartnett is the founder and director of Pediatric Retina at the John A. Moran Eye Center and principal investigator of the Retinal Angiogenesis Laboratory.
As director of Moran's Pediatric Retina Center, Dr. Hartnett is one of a few pediatric retina specialists internationally trained to diagnose and treat pediatric retina disorders, which disrupt the healthy development of the light-sensitive tissue at the back of the eye. There are dozens of conditions that cause retinal blindness in infants and children, but most are rare. She is one of only a handful of pediatric retina specialists in the United States offering complete care for these challenging conditions. She also practices as a vitreoretinal surgeon, providing treatment to patients throughout the Mountain West. She performs surgery at both the Moran Eye Center and Primary Children's Hospital.
Her mission is to deliver the best possible care and education while conducting critical research to make future advances in pediatric retina care.
She created the first-ever academic textbook on the subject, Pediatric Retina, currently in the second edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally. She is a director of the Advances in Pediatric Retina meeting held every two years, most recently in 2019 at the University of Utah, serving to provide training in established and new methods to manage pediatric retinal conditions and to incite collaborations in research in pediatric retina.
Dr. Hartnett has received numerous awards, including the Physician-Scientist Merit Award from Research to Prevent Blindness; the Honorary Lecture Award and Scientific Contribution Award from Women in Ophthalmology; the Macula Society's Paul Henkind Award and Arnall Patz Medal; the Association for Research in Vision and Ophthalmology's (ARVO) Weisenfeld Award; and the Paul Kayser/RRF Global Award. She is an ARVO Gold Fellow.
Dr. Hartnett's prolific publication record includes more than 200 articles in peer-reviewed journals and 36 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, and as a mentor for the ARVO Leadership Development Program. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the Journal of the American Association for Pediatric Ophthalmology and Strabismus. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of Association for Research in Vision and Ophthalmology (FARVO).
She received her BS-MD from Rensselaer Polytechnic Institute and Albany Medical College, as part of a six-year biomedical program, and performed retinal fellowships in adult and pediatric retina at Schepens Retina Associates. Dr. Hartnett completed post-doctoral training at Harvard University/Schepens Eye Research Institute in retinal cell and molecular biology in the laboratory of Patricia D'Amore and then in GTPases and molecular cell biology at the University of North Carolina with Keith Burridge. She has served as Retinal Director for the residencies at State University of New York at Buffalo and Louisiana State University.
Clinical Locations
801-581-2352
Board Certification and Academic Information
| Academic Departments | Ophthalmology/Visual Sciences
-
Professor Neurobiology and Anatomy - Adjunct Professor Pediatrics - Adjunct Professor |
| Academic Divisions | Pediatric Administration |
| Board Certification | American Board of Ophthalmology |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.7/ 5
Care provider's explanation of condition/problem
4.6/ 5
Care provider's effort to include me in decisions
4.7/ 5
Wait time at clinic
4.2/ 5
Care provider's concern for questions & worries
4.7/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
February 28, 2021
MORAN EYE CENTER
good
UofU Patient
February 17, 2021
MORAN EYE CENTER
dr's are always amazing and so is the staff
UofU Patient
January 03, 2021
MORAN EYE CENTER
Great visit!
UofU Patient
December 07, 2020
MORAN EYE CENTER
Dr. Heartnett clealy explained and showed via scans the condition of my retina and the change since my last visit. She also shares her evaluation of the condition and her opinion on treatment. She clearly explains risk/benefits of potential treatments without being prescriptive. I never feel rushed or discounted when I have an exam.
UofU Patient
November 30, 2020
MORAN EYE CENTER
Good
UofU Patient
November 30, 2020
MORAN EYE CENTER
Dr. Hartnett is incredible. She has a terrific bedside manner and really cares about [NAME REMOVED]. She spent a few minutes reviewing previous procedures and talking about the planned surgery. She then followed up after anesthesia was administered to notify us of the surgical item necessary for [NAME REMOVED] healing. We were involved 100% of the time.
UofU Patient
November 28, 2020
MORAN EYE CENTER
Dr Hartnett is amazing! This has been a very difficult journey after our son's eye injury and she has taken such good care of him! It has definitely relieved the stress.
UofU Patient
October 11, 2020
MORAN EYE CENTER
excellent experience. friendly, well informed ,
UofU Patient
October 06, 2020
MORAN EYE CENTER
Just a very long wait. Inexcusable. And no one every told me anything about waits or what was going on.
UofU Patient
October 04, 2020
MORAN EYE CENTER
excellent
UofU Patient
August 10, 2020
MORAN EYE CENTER
always very professional
UofU Patient
June 26, 2020
MORAN EYE CENTER
Dr. Hartnett is monitoring an ongoing condition with my left retina. She clearly explains her observations regarding progression, and next steps (continue to monitor, possible surgery). She takes time to answer questions and answers clearly and completely.
UofU Patient
June 24, 2020
MORAN EYE CENTER
good
UofU Patient
June 09, 2020
MORAN EYE CENTER
Dr. Hartnett has always been most professional. My only issue is time management and waiting time. This visit was excellent.
UofU Patient
January 22, 2020
MORAN EYE CENTER
the resident doc and attending were in the room at different times,and the explanation of a possible procedure they each delivered was different, especially in terms of operative risk
UofU Patient
January 19, 2020
MORAN EYE CENTER
Dr. Hartnet is not only a skilled surgeon, but also a caring and compassionate care provider.
UofU Patient
December 29, 2019
MORAN EYE CENTER
wasn't explained to me as to why the doctor chose the option she did as to why she was operating on the eye she did and what it'd mean, the risks involved, the probability of her losing her vision in the only eye she had been able to see out of
UofU Patient
November 13, 2019
MORAN EYE CENTER
The Fellow and Dr. Heartnet both clearly explained their observations and assessment of my condition.
UofU Patient
October 13, 2019
MORAN EYE CENTER
very professional
UofU Patient
September 29, 2019
MORAN EYE CENTER
alll good
UofU Patient
September 27, 2019
MORAN EYE CENTER
Dr. Hartnett is an excellent doctor
UofU Patient
September 04, 2019
MORAN EYE CENTER
Exceptional, outstanding
UofU Patient
September 03, 2019
MORAN EYE CENTER
If not for the Fellow and the Doctor I would not come back
UofU Patient
August 18, 2019
MORAN EYE CENTER
Dr. Hartnett set my mind at ease regarding my concerns of possible cataract surgery in the future.
UofU Patient
August 18, 2019
MORAN EYE CENTER
always very thorough
UofU Patient
August 11, 2019
MORAN EYE CENTER
This provider is one of three in the nation with her specialty so we didn't have an option to see someone else. The provider was quick with her exam and changed the plan of action three times in 10 minutes.
UofU Patient
July 14, 2019
MORAN EYE CENTER
all good
UofU Patient
July 11, 2019
MORAN EYE CENTER
We love Dr. Harnett!!!
UofU Patient
June 10, 2019
MORAN EYE CENTER
Dr Hartnett was very informative and interested in my needs, as well as my concerns with the procedure and the future of my procedures and those cases that were successful. I really appreciated the "information packet" she gave me for reference as well as future instructions.
UofU Patient
May 13, 2019
MORAN EYE CENTER
Just delightful Doctors ! Very positive !
UofU Patient
April 21, 2019
MORAN EYE CENTER
Dr. Hartnett always shows exceptional concern for my eye health and emotional issues.
UofU Patient
April 04, 2019
MORAN EYE CENTER
I liked the doctor did not liked the staff and the wait time
UofU Patient
April 04, 2019
MORAN EYE CENTER
everyone is amazing !
UofU Patient
November 11, 2018
MORAN EYE CENTER
This was the first time in a long period of time that I actually meant with my primary care doctor and it was quite helpful. Normally she reviews photos taken and makes the decision for when a needed appointment needs to take place but this time she went over my pictures and explained what was taking place with my eyes. It was a nice experience.
UofU Patient
November 11, 2018
MORAN EYE CENTER
Dr. Hartnett is a great Doctor. I know she will take the best care of my kids.
UofU Patient
November 09, 2018
MORAN EYE CENTER
I think Dr Harnett is great. She is thorough and straightforward. I read other bad reviews about bedside behavior before our visit and both times we've seen her, she has been kind, patient and straightforward. I think the ones who wrote those reviews were probably sensitive. She is great and I will continue to have my son see her.
UofU Patient
October 28, 2018
MORAN EYE CENTER
I would appreciate the use of simple terminology. The last year I have had to research the words my doctors tell me in my appointments and on mychart website.
UofU Patient
October 25, 2018
MORAN EYE CENTER
It was Dr. Eric Hansen and he did an excellent and thorough job of the examination and caring for me. I had concerns about something happening in my eye and through a thorough exam he was able to allay my fears and nothing bad that I feared has happened since then
UofU Patient
October 21, 2018
MORAN EYE CENTER
dr hartnett was great. she was patient and kind. she seemed to really care and wants to give us answers. very thorough.
UofU Patient
October 08, 2018
MORAN EYE CENTER
Dr Hartnett is wonderful
UofU Patient
October 06, 2018
MORAN EYE CENTER
GOOD
UofU Patient
September 13, 2018
MORAN EYE CENTER
Dr Hartnet was caring and very concerned about the macular hole. She was very thorough about what needed to be done to repair it. She listened as I discussed my negative experinces with my last surgery with another care provider. She didn't disparage the other provider, but she was firm in what she felt was the correct and ost successful way to handle the surgery and aftercare.
UofU Patient
September 04, 2018
MORAN EYE CENTER
My eye injection was changed to a stronger dosage. She took the time to explain that seeing if this worked better and explained that the outward experience of the injection would be the same.
UofU Patient
August 20, 2018
MORAN EYE CENTER
Dr Hartnett is a fabulous, caring, highly skilled doctor which is the reason I sought her out. She is overbooked and unable to give the attention she needs to each patient. We were never seen by her again after an additional test she requested to answer our questions. We left frustrated and highly disappointed after waiting almost two months to have an appointment.
UofU Patient
June 30, 2018
she is one of the best docs ever. she always explains everything to me. she is very skilled and I have total confidence in her
UofU Patient
June 26, 2018
Dr. Hartnett was very personable with my son during his visit. She was very thorough at explaining information and procedures. She was great to work with!
UofU Patient
June 22, 2018
I felt like she answered my specific questions briefly, but wasn't thorough with any explanation on this disease beyond my questions and stood next to the door, holding the handle as if she was in a hurry to get on to the next patient.
UofU Patient
May 14, 2018
Dr Hartnett showed great concern and caution in analyzing and exploring a side effect of my condition. She brought in additional resources to assess it and explored alternative solutions.
UofU Patient
April 30, 2018
Dr. Hartnett has always been extremely friendly and courteous. She explains everything very well and we have always been impressed with her care for our son ______.
UofU Patient
March 20, 2018
The PA that saw us first was very kind and patient with my two-year-old which I sincerely appreciate and was very impressed. Anyone with children know that toddlers do not have a long attention span or hold still. I wish I could remember this gentleman's name, but I can't. (He has red hair :0) I would give him high ratings as he worked very well with my young patient and was genuine and sincere. Our experience with the doctor was different. Although she was courteous, she was less than patient with my two-year-old. I recognize that the majority of patients are probably not that young, but still...After a toddler has been waiting for sometime while eyes are dilated and already having been seen by the PA, it would be difficult for a toddler to focus and hold still. Her lack of patience was evident. I felt the doctor's time was short and impersonal. I was expected to know everything about my child's condition already and my questions/concerns about upcoming procedures were not fully addressed. Our last visit was six months prior. I can't say that I remember or even know all those medical terms. More time spent in explaining my child's situation would have been helpful. More patience and understanding towards young patients would have made our experience a more positive one.
UofU Patient
March 10, 2018
she was very busy. she offered for us to Saturday after clinic to answer any questions. we chose not to. she was upfront and honest
UofU Patient
March 04, 2018
I feel like this app was an outlier however I am not happy with the visit, wait time and not being informed.
UofU Patient
February 17, 2018
Patients at Moran are most fortunate to be under the care of Dr. Hartnett and her staff.
UofU Patient
January 26, 2018
You are superstars in my opinion!
UofU Patient
January 18, 2018
This is our second visit with Dr. Hartnet, our first appt went very well. At this appt she was extremely short with her MA and when giving instructions to my child. The whole appt was very uncomfortable and she seemed very unprofessional.
UofU Patient
January 17, 2018
After waiting with our 4 month old and 3 year old for 1.5 hours, we were finally seen. We were placed into the procedure room, which seemed more like a storage room with old Starbucks beverages in the room. After the exam, it seemed as though there was no need for us to be in that room (maybe our children were being too loud)? The doctor came in and looked over the referral from the pediatric opthomologist that we saw in Rexburg, ID. The doctor then examined our daughter's eyes and did seem to get a good look at them. After that, she proceeded to type on her computer for approximately 2-3 minutes without saying a word or prompting us with any information as to why. She then diagnosed our daughter with a bilateral coloboma, which we were already aware of from the previous opthomologist we saw. After that, the disorganization and floodgates of information started flowing. I felt as though information was provided in spurts and I had to piece things together to try to understand. I felt as though I was being talked over and not provided with information that I understood. I also felt as though I was being provided with all the clinical research about this issue, and nothing personalized to my daughter. It would've been nice to be asked a question like "What do you see at home?" I am confident that the provider made all the necessary referrals and I am happy that the rest of the Moran Eye Center staff figured the rest out for us. Dr. Ricks stepped in and gave us great assistance
UofU Patient
December 11, 2017
We will always come here now. we have already told our friends and family.
UofU Patient
December 10, 2017
Dr. Hartnett is extremely compassionate and professional. greeting with a handshake is really nice. she always listens attentively and with genuine concern. I had to wait an hour to see her, but I guess that's okay because I truly value her expertise.
UofU Patient
December 05, 2017
The doctor seemed insensitive, clumsy, and hurried.
UofU Patient
November 09, 2017
it was a pleasure being there
UofU Patient
November 05, 2017
Dr. Hartnett is superb.
UofU Patient
October 23, 2017
Both the doctor and her assistant took the time to make sure that my concerns were addressed and I was put at ease over them.
UofU Patient
September 29, 2017
I would recommend Moran as well as Dr. Hartnett to anyone and everyone.
UofU Patient
August 09, 2017
All excellent.
UofU Patient
July 24, 2017
I appreciate the openness and honesty of Dr. Hartnett and her expertise. She ultimately gave us the decision on how to proceed but we trust her expert opinion and feel comfortable following her recommendations.
UofU Patient
July 15, 2017
Doctor Hartnett is wonderful. Before she came in, another doctor with a student named Juliann (I think?) examined my eye and drew Juliann's attention to things she should notice about my eye. The light was bright -- in fact, quite painfully bright. It further reminded me of how wonderful Doctor Hartnett is. She seems to dial back the intensity of the examination light to where I'm really not in much pain at all. (Same with Doctor Churgin). She really is wonderful and I'm so glad that she is in charge of treating my detached retinal condition.
UofU Patient
June 28, 2017
Due to the urgency of my injury, the providers spent a good deal of time making sure they got a good diagnosis and making sure I understood all of the steps toward recovery.
UofU Patient
June 25, 2017
I did not feel rushed. Dr. Hartnett is most professional and very compassiionate.
UofU Patient
June 15, 2017
We love Dr. Hartnett and Dr. Churgin (Churkin?)No medications after this visit.
UofU Patient
June 15, 2017
On Saturday, Dr., uh, Wellington, I think? Anyway, he was super nice and I think he answered all of _________'s (my wife) questions to her satisfaction.Also, before the surgery, I was still holding out hope that my eye was responding well enough to the earlier cryogenic treatment (I'm self pay, and was hoping to minimize costs). Dr. Hartnett was so sweet and had Dr. Churgin (Spelling?) take one last evaluation before doing the surgery. I really appreciated her doing that.
UofU Patient
June 06, 2017
the doctor did not speak with me after my surgery my husband contacted the doctor and asked several questions as to my aftercare and what he was supposed to do to get the adhesive off of my eyes so I could open my eyelids. We did not know that we had a appointment the next day the doctor informed my husband of this appointment on the phone.
UofU Patient
June 04, 2017
I felt secure in the decision to delay my diagnosis for 6 weeks because they took the time to explain this decision until I understood it. They understood I was very tired, my eyes were hurting and tired, but they were very patient with me. I appreciated this more than I can say.
UofU Patient
May 04, 2017
Dr Hartnett is excellent, you feel confident you are in good hands and she is also very calming
UofU Patient
March 19, 2017
superior
UofU Patient
February 09, 2017
I like Dr. Hartnett very much. I think she is extremely capable.
UofU Patient
December 27, 2016
We assumed that the doctor meant for us to continue with the eyedrops that our son was taking, but she didn't say so. We remembered to ask on our way out and had a surprisingly hard time getting an answer. From there began a saga that took several days to resolve (a prescription finally called in but for a different drug and with no explanation, etc.). A little bit of communication could have saved a lot of frustration.
UofU Patient
December 23, 2016
you are always recomanded
UofU Patient
October 28, 2016
excellent experience
UofU Patient
October 25, 2016
Dr. Hartnett was super. She is genuinely concerned about doing what is in my best interest.
UofU Patient
October 17, 2016
We have been very pleased with Hartnet and would recommend her and have.
UofU Patient
August 28, 2016
Medication (eye injection) was changed but care provider was not seen until injection and nothing was ever said about the change.
UofU Patient
July 31, 2016
I have never feel rushed during my exam.
UofU Patient
July 19, 2016
gpod
UofU Patient
June 05, 2016
I had a very bad experience with medical care 23 yrs ago when I lived in San Diego,Ca. I told myself I would never have any kind of surgery again unless my life depended on it. You folks are fantastic, from the receptionist to Dr Hartnett, everyone was truly wonderful and you changed my attitude towards medical providers, THANK YOU !
UofU Patient
June 03, 2016
if there was a score of 7 I would have given it in all cases!
UofU Patient
May 15, 2016
Dr. Hartnett and Dr. Warner are very knowledgeable. They have treated my brother so well giving him better vision and working also so well with my brother's Doctors team.
UofU Patient
May 01, 2016
excellent
UofU Patient
April 10, 2016
superior
UofU Patient
April 07, 2016
It was a very awesome experience and we very much appreciate those who helped us-you guys are terrific
UofU Patient
March 07, 2016
Just want to have this problem that seems to have stumped the doctors here at Moran. I wish they would reach out to other specialists perhaps at other great care Facilities for specific eye problems similar and perhaps other treatment options. I would be willing to travel anywhere to find some answers As to if my issue is permanent or a reasonable treatment available
UofU Patient
February 25, 2016
Excellent experience
UofU Patient
January 26, 2016
She's one of the best, most careful and most competent MD's I've ever known. She truly cares about her patients! Thank you Dr. Hartnett!
UofU Patient
January 22, 2016
After waiting 55 minutes in the waiting room, and another 15 in the exam room before we were seen, it was EXTREMELY frustrating and disheartening that we were told she only had a couple minutes before she had to run off to some other appointment that was obviously much more important than we were. We understand that things get behind, but the lack of respect that we were shown, the interest in answering our questions, and making sure we felt comfortable with what was happening, and what was to happen until the next appointment was awful!! Our time is just as important; and to be discarded like we felt we were is simply unacceptable!
UofU Patient
November 09, 2015
Dr. Hartnett always treats me courteously and answers questions. I was pleasantly surprised by her resident Dr. James (W?) who loved his work and was GREAT about providing information. I'm sorry I can't quite remember his last name.
UofU Patient
November 05, 2015
excellent experience
UofU Patient
October 26, 2015
couldn't have been a better experience
UofU Patient
October 06, 2015
over the top
UofU Patient
October 03, 2015
Hartnett and her team are wonderful!
UofU Patient
September 13, 2015
good
UofU Patient
September 06, 2015
Always kept me informed.
UofU Patient
August 03, 2015
I am just frustrated with the situation and how nothing is working and we are not seeing any progress.
UofU Patient
July 26, 2015
Dr. Hartnett did speak over my head frequently, I had to use my daughter who is my caregiver and nurse to translate everything for me later on. Though Dr. Hartnett did address all of my concerns I did feel that she was rushing through to move on to her next patient.
UofU Patient
July 26, 2015
Dr. Hartnett is conscientious, concerned, caring, and I have full trust in her surgical skills, judgement, and expertise.
UofU Patient
July 16, 2015
Both Dr Teske and Dr. Hartnett have been thorough and knowledgeable in my care of my two conditions. The system failure occurred through the failure of your phone system in forwarding my two calls to the on call physician when I experienced encroaching blindness of my left eye visual field.
UofU Patient
July 01, 2015
Dr, Hartnett spent a good amount of time explaining what was going on within my eye. I felt very reassured about the treatment. I felt she knew exactly what she was talking about and this put me at ease.
UofU Patient
July 01, 2015
Dr. Hartnett was absolutely amazing. She explained everything to me in laymen's terms and made sure I understand what needed to happen. Her manner was kind, confident and I felt she was personally concerned with what was happening to me.
UofU Patient
May 25, 2015
Dr. Hartnett was not able to answer some of my questions during my first appointment, so this time I brought a list. She is a very capable, kind human being, who was actually pleased that I brought a list of questions. She explained my issues very well. I would recommend her highly as a physician, and yet I am frustrated by the wait time I have experienced at Moran/University of Utah hospital. Yes, I want patients ahead of me to receive good health care also, and I want their issues to be resolved. At the same time, my visit is not enhanced by waiting in a stuffy dark room wondering what is going on. I think the U needs to seriously evaluate this scheduling problem.
UofU Patient
April 13, 2015
I like Mary Hartnett and have faith in her.
UofU Patient
February 09, 2015
Just a great facility and staff.
UofU Patient
January 23, 2015
Dr. Hartnett's office seems very organized . I have never spent much time waiting.
UofU Patient
January 21, 2015
Dr. Hartnet was excellent.
UofU Patient
January 12, 2015
As stated before it would be nice to get an update from the doctor on how she felt my eyes was responding to the treatment.
UofU Patient
December 15, 2014
No problem
UofU Patient
December 02, 2014
I did repeat my self 3 times ,same questions from the nurse then the intern then the Doctor , it gets a bit tedious but all were very good thanks
UofU Patient
November 29, 2014
I had a superb experience.
UofU Patient
November 16, 2014
every thing was taken care of very well.
UofU Patient
October 10, 2014
Dr. Hartnett is fantastic. So happy with everything she has done for my family. God bless her.
UofU Patient
September 12, 2014
Dr. Hartnett always shows genuine concern for my care, takes time to explain my options and helps me to make best decision. I very much appreciate her and those that work with her.
UofU Patient
July 31, 2014
excellent
UofU Patient
July 18, 2014
I would recommend Dr. Hartnett without hesitation.
UofU Patient
July 06, 2014
Dr. Hartnett has always been very good about communicating information and options. I feel that she genuinely cares about me as her patient.
UofU Patient
June 08, 2014
the MD was fine. The wait time is too long for me to recommend this facility to others for eye care.
UofU Patient
May 25, 2014
Moran Eye Center is a great service to have so close by.
UofU Patient
May 25, 2014
I was very impressed with doctors I saw, made a frightening experience not bad at all.
UofU Patient
May 19, 2014
Dr Hartnet is AMAZING!!!!
UofU Patient
April 28, 2014
GOOD EXPERIENCE
UofU Patient
March 30, 2014
Could have been better if physician and fellow examined at same time so I wouldn't have to have discomfort of lights twice.
UofU Patient
March 17, 2014
Doctor Hartnet is very professional and caring with patients--she includes me in decisions--I credit her with saving my sight in my right eye---she is an excellent physican----
UofU Patient
February 12, 2014
The care that I receive from Dr Hartnett is very good and she explains things well. However the assistant that dilated my eyes when they should not have been was not good at all.
UofU Patient
December 22, 2013
Dr. Hartnet was always very caring, engaged and helpful. A couple of her assistants/fellows (?) were less so and maybe even a little rough during exam of retinal tear (however, that may have been absolutely necessary. Dr. Hartnet was more gentle in her approach).
UofU Patient
November 28, 2013
I am usually seen by Dr. Hobbs and then by Dr. Hartnett. Both are very professional, and have done a wonderful job with my complicated case.
UofU Patient
November 18, 2013
Excellent.
UofU Patient
November 18, 2013
We would recommend Dr. Hartnett but the wait time was excessive. Also we were sent out to the reception waiting room and then called back into an exam room to schedule a procedure. We had to wait again for the person scheduling the procedure. It just seemed like the flow of how things ran there needed some work.
UofU Patient
November 11, 2013
Dr. B was awesome. He was straight forward explaining the situation to me abt what was happening and might happen with my retina. Too bad he couldn't/didn't need to stay longer and visit. I like him.
UofU Patient
October 21, 2013
I never saw the physician, just her fellow.
UofU Patient
October 14, 2013
I am always thankful for specialists. They have worked hard for their knowledge.
UofU Patient
October 07, 2013
Dr. Hartnett is clearly a consummate professional who is willing to explain and discuss my condition and the possible need for further treatment.
UofU Patient
October 07, 2013
Dr. Hartnett has been fantastic. She has done everything possible to deal with my difficult case with the best possible outcome.
UofU Patient
September 09, 2013
I have a problem with hearing when I can't see. Another thing I have a problem with is that by the time they actual DR comes in I am so dilated that I can't see the Dr.'s face. I don't know what she looks like.
UofU Patient
September 09, 2013
We drive 4 hours in order to see Dr. Lenahan, she is incredible to work with. I wouldn't want to see another provider even if they were "in-network"!
UofU Patient
September 02, 2013
okay. Primary Doctors time with us was limited
UofU Patient
August 08, 2013
Good
UofU Patient
July 15, 2013
I think there is a disconnect between me and the care provider. The care provider seems to be focusing her attention on my good eye where I really am still concerned with my bad eye. I could really use some help in knowing what I can do to minimize the symptoms or resolve the problem. I feel lost. I cannot describe the difficulties i've had in trying to cope with this and yet I feel like i'm left on my own to try and figure it out.
UofU Patient
June 05, 2013
I was unable to see the doctor - my contact lenses were out. But he was terrific. Very competent and patient.
UofU Patient
June 04, 2013
thanks to dr harnet my son can see!!!!!!!!!!!!!!
UofU Patient
April 01, 2013
everything was excellent except for the LONG wait.
UofU Patient
February 26, 2013
I am extremely impressed with the way doctor hartnett, and shokor(spelled wrong) diagnosed my problem. I've never been shown that kind and that much attention to any of my problems ever. Dr. Hartnett even came back after emergency surgery to make sure I was seen and looked at. I really felt like they cared and they wanted to make sure I was diagnosed correctly. My problem I know is a difficult one to diagnose, but I know they will find out what the problem is and help me. I would highly recommend others to go to the Moran eye center.
UofU Patient
February 18, 2013
Dr. Hartnet and the other doctor were very nice and thorough
UofU Patient
November 12, 2012
dr hartnet is the best pediatric retna specialist. she has a great bedside manner
UofU Patient
November 06, 2012
I have a serious retinal condition and these guys/gals knew what they were doing/talking about. Excellent facility.
UofU Patient
November 05, 2012
Dr. Hartnett pays such close attention my description of symptoms, and my physical exam is so meticulous. Her analysis of the situation is transparent which I appreciate.
Mary Elizabeth Hartnett, MD, holds the Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences and is a Distinguished Professor at the University of Utah. She is an adjunct professor at the University of Utah departments of Neurobiology, Anatomy, and Pediatrics. Dr. Hartnett is the founder and director of Pediatric Retina at the John A. Moran Eye Center and principal investigator of the Retinal Angiogenesis Laboratory.
As director of Moran's Pediatric Retina Center, Dr. Hartnett is one of a few pediatric retina specialists internationally trained to diagnose and treat pediatric retina disorders, which disrupt the healthy development of the light-sensitive tissue at the back of the eye. There are dozens of conditions that cause retinal blindness in infants and children, but most are rare. She is one of only a handful of pediatric retina specialists in the United States offering complete care for these challenging conditions. She also practices as a vitreoretinal surgeon, providing treatment to patients throughout the Mountain West. She performs surgery at both the Moran Eye Center and Primary Children's Hospital.
Her mission is to deliver the best possible care and education while conducting critical research to make future advances in pediatric retina care.
She created the first-ever academic textbook on the subject, Pediatric Retina, currently in the second edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally. She is a director of the Advances in Pediatric Retina meeting held every two years, most recently in 2019 at the University of Utah, serving to provide training in established and new methods to manage pediatric retinal conditions and to incite collaborations in research in pediatric retina.
Dr. Hartnett has received numerous awards, including the Physician-Scientist Merit Award from Research to Prevent Blindness; the Honorary Lecture Award and Scientific Contribution Award from Women in Ophthalmology; the Macula Society's Paul Henkind Award and Arnall Patz Medal; the Association for Research in Vision and Ophthalmology's (ARVO) Weisenfeld Award; and the Paul Kayser/RRF Global Award. She is an ARVO Gold Fellow.
Dr. Hartnett's prolific publication record includes more than 200 articles in peer-reviewed journals and 36 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, and as a mentor for the ARVO Leadership Development Program. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the Journal of the American Association for Pediatric Ophthalmology and Strabismus. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of Association for Research in Vision and Ophthalmology (FARVO).
She received her BS-MD from Rensselaer Polytechnic Institute and Albany Medical College, as part of a six-year biomedical program, and performed retinal fellowships in adult and pediatric retina at Schepens Retina Associates. Dr. Hartnett completed post-doctoral training at Harvard University/Schepens Eye Research Institute in retinal cell and molecular biology in the laboratory of Patricia D'Amore and then in GTPases and molecular cell biology at the University of North Carolina with Keith Burridge. She has served as Retinal Director for the residencies at State University of New York at Buffalo and Louisiana State University.
Academic Locations
John A. Moran Eye Center
Board Certification and Academic Information
| Academic Departments | Ophthalmology/Visual Sciences
-
Professor Neurobiology and Anatomy - Adjunct Professor Pediatrics - Adjunct Professor |
| Academic Divisions | Pediatric Administration |
| Board Certification | American Board of Ophthalmology |
Education History
| Post Graduate Training | Children’s Hospital and Schepens Eye Research Institute, Harvard University Molecular and Cell Biology Postgraduate Studies |
| Fellowship | Schepens Retina Associates, Massachusetts Eye and Ear Infirmary, Harvard Medical School Vitreoretinal Medical/Surgical Training in Pediatric Retina Fellow |
| Research Fellow | Harvard University Senior Research Ophthalmology Fellow Research Fellow |
| Fellowship | Schepens Retina Associates Chief Fellow |
| Fellowship | Massachusetts Eye and Ear Infirmary, Harvard Medical School, Schepens Retina Associates Vitreoretinal Medical/Surgical Training in Adult Retina Fellow |
| Research Fellow | Schepens Eye Research Institute, Harvard Medical School Research Fellow |
| Residency | University Hospitals of Cleveland, VA Medical Center Ophthalmology Resident |
| Internship | University Hospitals of Cleveland Intern |
| Professional Medical | Albany Medical College Medicine (Combined BS/MD program) M.D. |
| Undergraduate | Rensselaer Polytechnic Institute Biology (Combined BS/MD program) B.S. |
| Other Training | St. Peter's Hospital Hospice Team Training |
Selected Publications - Journal Articles
Journal Article
- Wang H, Ramshekar A, Kunz E, Hartnett ME (2021). 7-ketocholesterol induces endothelial-mesenchymal transition and promotes fibrosis: implications in neovascular age-related macular degeneration and treatment. (Epub ahead of print) Angiogenesis.
- Stagg BC, Stein JD, Medeiros FA, Wirostko B, Crandall A, Hartnett ME, Cummins M, Morris A, Hess R, Kawamoto K (2020). Special Commentary: Using Clinical Decision Support Systems to Bring Predictive Models to the Glaucoma Clinic. Ophthalmol Glaucoma, 4(1), 5-9.
- Hicks PM, Haaland B, Feehan M, Crandall AS, Pettey JH, Nuttall E, Self W, Hartnett ME, Bernstein P, Vitale A, Shakoor A, Shulman JP, Sieminski SF, Kim I, Owen LA, Murtaugh MA, Noyes A, DeAngelis MM (2020). Systemic Disease and Ocular Comorbidity Analysis of Geographically Isolated Federally Recognized American Indian Tribes of the Intermountain West. J Clin Med, 9(11).
- Hartnett ME (2020). Retinopathy of Prematurity: Evolving Treatment With Anti-Vascular Endothelial Growth Factor. Am J Ophthalmol, 218, 208-213.
- Levine ES, Custo Greig E, Mendona LSM, Gulati S, Despotovic IN, Alibhai AY, Moult E, Muakkassa N, Quaranta-El Maftouhi M, El Maftouhi A, Chakravarthy U, Fujimoto JG, Baumal CR, Witkin AJ, Duker JS, Hartnett ME, Waheed NK (2020). The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration. Int J Retina Vitreous, 6, 39.
- Bretz CA, Ramshekar A, Kunz E, Wang H, Hartnett ME (2020). Signaling Through the Erythropoietin Receptor Affects Angiogenesis in Retinovascular Disease. Invest Ophthalmol Vis Sci, 61(10), 23.
- Hamad AE, Moinuddin O, Blair MP, Schechet SA, Shapiro MJ, Quiram PA, Mammo DA, Berrocal AM, Prakhunhungsit S, Cernichiaro-Espinosa LA, Mukai S, Yonekawa Y, Ung C, Holz ER, Harper CA 3rd, Young RC, Besirli CG, Nagiel A, Lee TC, Gupta MP, Walsh MK, Khawly JA, Campbell JP, Kychenthal A, Nudleman ED, Robinson JE, Hartnett ME, Calvo CM, Chang EY (2019). Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity. Ophthalmol Retina, 4(6), 602-612.
- Global Retinoblastoma Study Group, Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A, Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaily U, Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al-Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R, Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam J, Caldern-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G, Castillo L, Catal-Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B, Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcroft RL, Comsa C, Correa ZM, Correa Llano MG, Corson TW, Cowan-Lyn KE, Cska M, Cui X, Da Gama IV, Dangboon W, Das A, Das S, Davanzo JM, Davidson A, De Potter P, Delgado KQ, Demirci H, Desjardins L, Diaz Coronado RY, Dimaras H, Dodgshun AJ, Donaldson C, Donato Macedo CR, Dragomir MD, Du Y, Du Bruyn M, Edison KS, Eka Sutyawan IW, El Kettani A, Elbahi AM, Elder JE, Elgalaly D, Elhaddad AM, Elhassan MMA, Elzembely MM, Essuman VA, Evina TGA, Fadoo Z, Fandio AC, Faranoush M, Fasina O, Fernndez DDPG, Fernndez-Teijeiro A, Foster A, Frenkel S, Fu LD, Fuentes-Alabi SL, Gallie BL, Gandiwa M, Garcia JL, Garca Aldana D, Gassant PY, Geel JA, Ghassemi F, Girn AV, Gizachew Z, Goenz MA, Gold AS, Goldberg-Lavid M, Gole GA, Gomel N, Gonzalez E, Gonzalez Perez G, Gonzlez-Rodrguez L, Garcia Pacheco HN, Graells J, Green L, Gregersen PA, Grigorovski NDAK, Guedenon KM, Gunasekera DS, Gndz AK, Gupta H, Gupta S, Hadjistilianou T, Hamel P, Hamid SA, Hamzah N, Hansen ED, Harbour JW, Hartnett ME, Hasanreisoglu M, Hassan S, Hassan S, Hederova S, Hernandez J, Hernandez LMC, Hessissen L, Hordofa DF, Huang LC, Hubbard GB, Hummlen M, Husakova K, Hussein Al-Janabi AN, Ida R, Ilic VR, Jairaj V, Jeeva I, Jenkinson H, Ji X, Jo DH, Johnson KP, Johnson WJ, Jones MM, Kabesha TBA, Kabore RL, Kaliki S, Kalinaki A, Kantar M, Kao LY, Kardava T, Kebudi R, Kepak T, Keren-Froim N, Khan ZJ, Khaqan HA, Khauv P, Kheir WJ, Khetan V, Khodabande A, Khotenashvili Z, Kim JW, Kim JH, Kiratli H, Kivel TT, Klett A, Komba Palet JEK, Krivaitiene D, Kruger M, Kulvichit K, Kuntorini MW, Kyara A, Lachmann ES, Lam CPS, Lam GC, Larson SA, Latinovic S, Laurenti KD, Le BHA, Lecuona K, Leverant AA, Li C, Limbu B, Long QB, Lpez JP, Lukamba RM, Lumbroso L, Luna-Fineman S, Lutfi D, Lysytsia L, Magrath GN, Mahajan A, Majeed AR, Maka E, Makan M, Makimbetov EK, Manda C, Martn Begue N, Mason L, Mason JO 3rd, Matende IO, Materin M, Mattosinho CCDS, Matua M, Mayet I, Mbumba FB, McKenzie JD, Medina-Sanson A, Mehrvar A, Mengesha AA, Menon V, Mercado GJVD, Mets MB, Midena E, Mishra DKC, Mndeme FG, Mohamedani AA, Mohammad MT, Moll AC, Montero MM, Morales RA, Moreira C, Mruthyunjaya P, Msina MS, Msukwa G, Mudaliar SS, Muma KI, Munier FL, Murgoi G, Murray TG, Musa KO, Mushtaq A, Mustak H, Muyen OM, Naidu G, Nair AG, Naumenko L, Ndoye Roth PA, Nency YM, Neroev V, Ngo H, Nieves RM, Nikitovic M, Nkanga ED, Nkumbe H, Nuruddin M, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oliver SCN, Osei-Bonsu P, Ossandon D, Paez-Escamilla MA, Pagarra H, Painter SL, Paintsil V, Paiva L, Pal BP, Palanivelu MS, Papyan R, Parrozzani R, Parulekar M, Pascual Morales CR, Paton KE, Pawinska-Wasikowska K, Peer J, Pea A, Peric S, Pham CTM, Philbert R, Plager DA, Pochop P, Polania RA, Polyakov VG, Pompe MT, Pons JJ, Prat D, P (2020). Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol, 6(5), 685-695.
- Bretz CA, Simmons AB, Kunz E, Ramshekar A, Kennedy C, Cardenas I, Hartnett ME (2020). Erythropoietin Receptor Signaling Supports Retinal Function after Vascular Injury. Am J Pathol, 190(3), 630-641.
- Wang H, Kunz E, Stoddard GJ, Hauswirth WW, Hartnett ME (2019). Optimal Inhibition of Choroidal Neovascularization by scAAV2 with VMD2 Promoter-driven Active Rap1a in the RPE. Sci Rep, 9(1), 15732.
- Mastey RR, Georgiou M, Langlo CS, Kalitzeos A, Patterson EJ, Kane T, Singh N, Vincent A, Moore AT, Tsang SH, Lin JH, Young MP, Hartnett ME, Hon E, Kohl S, Michaelides M, Carroll J (2019). Characterization of Retinal Structure in ATF6-Associated Achromatopsia. Invest Ophthalmol Vis Sci, 60(7), 2631-2640.
- Hartnett ME, Toth CA (2019). Experimental Evidence Behind Clinical Trial Outcomes in Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina, 50(4), 228-234.
- Jeng-Miller KW, Soomro T, Scott NL, Rao P, Marlow E, Chang EY, Ells A, Chau F, Nudleman E, Calvo CM, Patel N, Schwartz R, Cernichiaro-Espinosa LA, Montoya AG, Goldstein J, Harper CA 3rd, Baumal CR, Hartnett ME, Harbour JW, Besirli CG, Gupta MP, Chan RVP, Drenser KA, Capone A Jr, Murray TG, Mukai S, Trese MT, Berrocal AM, Wong SC, Yonekawa Y (2019). Longitudinal Examination of Fellow-Eye Vascular Anomalies in Coats' Disease With Widefield Fluorescein Angiography: A Multicenter Study. Ophthalmic Surg Lasers Imaging Retina, 50(4), 221-227.
- Mangalesh S, Bleicher ID, Chen X, Viehland C, LaRocca F, Izatt JA, Freedman SF, Hartnett ME, Toth CA (2019). Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol, 257(4), 677-688.
- Hartnett ME (2019). Discovering Mechanisms in the Changing and Diverse Pathology of Retinopathy of Prematurity: The Weisenfeld Award Lecture. Invest Ophthalmol Vis Sci, 60(5), 1286-1297.
- Han X, Kong J, Hartnett ME, Wang H (2019). Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci, 60(5), 1604-1613.
- Hicks PM, Melendez SAC, Vitale A, Self W, Hartnett ME, Bernstein P, Morgan DJ, Feehan M, Shakoor A, Kim I, Owen LA, DeAngelis MM (2019). Genetic Epidemiologic Analysis of Hypertensive Retinopathy in an Underrepresented and Rare Federally Recognized Native American Population of the Intermountain West. J Community Med Public Health, 3(1).
- Hansen ED, Hartnett ME (2019). A review of treatment for retinopathy of prematurity. Expert Rev Ophthalmol, 14(2), 73-87.
- Greene T, Hartnett ME (2018). Programming Error Led to Underestimate of Effect Sizes in Study of Association of Maternal Preeclampsia and Risk of Infant Retinopathy of Prematurity. JAMA Ophthalmol, 137(1), 119.
- Yarishkin O, Phuong TTT, Bretz CA, Olsen KW, Baumann JM, Lakk M, Crandall A, Heurteaux C, Hartnett ME, Kriaj D (2018). TREK-1 channels regulate pressure sensitivity and calcium signaling in trabecular meshwork cells. J Gen Physiol, 150(12), 1660-1675.
- Simmons MA, Cheng AV, Becker S, Gerkin RD, Hartnett ME (2018). Automatic analysis of the retinal avascular area in the rat oxygen-induced retinopathy model. Mol Vis, 24, 767-777.
- Shulman JP, Hartnett ME (2018). Corrigendum: Pharmacotherapy and ROP: Going Back to the Basics. Asia Pac J Ophthalmol (Phila), 7(5), 365.
- Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NL, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (2018). Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856.
- Zayed MA, Uppal A, Hartnett ME (2010). New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 51(10), 4983-8.
- Sleath B, Blalock SJ, Robin A, Hartnett ME, Covert D, DeVellis B, Giangiacomo A (2010). Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Eye (Lond), 24(4), 624-31.
- Budd SJ, Hartnett ME (2010). Increased Angiogenic Compounds during Persistent Avascular Retina in a Model of ROP. Arch Ophthalmol, 128(8), 1014-21.
- Hartnett ME, Tinkham N, Paynter L, Geisen P, Rosenberg P, Koch G, Cohen KL (2009). Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol, 148(6), 895-901.e1.
- Budd S, Byfield G, Martiniuk D, Geisen P, Hartnett ME (2009). Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res, 89(5), 718-27.
- Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J (2009). CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature, 460(7252), 225-30.
- Byfield G, Budd S, Hartnett ME (2009). The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Invest Ophthalmol Vis Sci, 50(7), 3360-5.
- Scott IU, Blodi BA, Ip MS, Vanveldhuisen PC, Oden NL, Chan CK, Gonzalez V (2009). SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type. Ophthalmology, 116(4), 756-61.
- Ulmasov B, Bruno J, Gordon N, Hartnett ME, Edwards JC (2009). Chloride intracellular channel protein-4 functions in angiogenesis by supporting acidification of vacuoles along the intracellular tubulogenic pathway. Am J Pathol, 174(3), 1084-96.
- Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C (2009). Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol, 127(3), 245-51.
- Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M (2009). SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology, 116(3), 504-12.
- Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA 3rd (2009). Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol, 127(2), 132-40.
- Reynolds R, Hartnett ME, Rosner B, Atkinson J, Giclas PC, Seddon JM (2009). Plasma Complement Components and Activation Fragments are Associated with Age-Related Macular Degeneration Genotypes and Phenotypes. Invest Ophthalmol Vis Sci.
- Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H (2008). Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology, 115(8), 1366-71, 1371.e1.
- Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008). Vascular endothelial growth factor in eye disease. Prog Retin Eye Res, 27(4), 331-71.
- Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch VL (2008). Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci, 49(7), 3107-14.
- Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H (2008). A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina, 28(7), 919-30.
- Davis MD, Bressler SB, Aiello LP, Bressler NM, Browning DJ, Flaxel CJ, Fong DS, Foster WJ, Glassman AR, Hartnett ME, Kollman C, Li HK, Qin H, Scott IU (2008). Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci, 49(5), 1745-52.
- Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, Danis RP, Elman MJ, Friedman SM, Glassman AR, Gross JG, Li HK, Murtha TJ, Stone TW, Sun JK (2008). Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol, 145(5), 894-901.
- Saito Y, Uppal A, Byfield G, Budd S, Hartnett ME (2008). Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Invest Ophthalmol Vis Sci, 49(4), 1591-8.
- Hartnett ME, Board RJ, Houghton O (2008). Subretinal hemorrhage after lens-sparing vitrectomy in infants born at or under 24 weeks gestation. Retina, 28(3 Suppl), S69-74.
- Vinekar A, Trese MT, Capone A Jr (2008). Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol, 145(3), 548-555.
- Geisen P, Peterson LJ, Martiniuk D, Uppal A, Saito Y, Hartnett ME (2008). Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis, 14, 345-57.
- Scott IU, Bressler NM, Bressler SB, Browning DJ, Chan CK, Danis RP, Davis MD, Kollman C, Qin H (2008). Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina, 28(1), 36-40.
- Diabetic Retinopathy Clinical Research Network (2008). A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology, 115, 1445-1456.
- Writing Committee for The Photographic Screening for Retinopathy of Prematurity Study Photo- ROP (2008). Primary Outcomes Ophthalmology. Retina, 28, S47-S54.
- Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, Jabs DA, Inokuma M, Maecker HT, Bredt B, and Sinclair E, for the Studies of Ocular Complications of AIDS Research Group (2008). Poor predictive value of cytomegalovirus (CMV)-Specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis, 46, 458-466.
- Zayed MA, Yuan W, Leisner TM, Chalothorn D, McFadden AW, Schaller MD, Hartnett ME, Faber JE, Parise LV (2007). CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesis. Circ Res, 101(11), 1185-93.
- Bhavsar AR, Ip MS, Glassman AR (2007). The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol, 144(3), 454-6.
- Diabetic Retinopathy Clinical Research Network (2007). Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology, 114(8), 1520-5.
- Saito Y, Geisen P, Uppal A, Hartnett ME (2007). Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis, 13, 840-53.
- Peterson LJ, Wittchen ES, Geisen P, Burridge K, Hartnett ME (2007). Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res, 84(4), 737-44.
- Diabetic Retinopathy Clinical Research Network (2007). Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol, 125(4), 469-80.
- Diabetic Retinopathy Clinical Research Network (2007). Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology, 114(3), 525-36.
- Zeng G, Taylor SM, McColm JR, Kappas NC, Kearney JB, Williams LH, Hartnett ME, Bautch VL (2007). Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood, 109(4), 1345-52.
- Steering Committee of Diabetic Retinopathy Clinical Research Network (2007). A phase 2 randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology, 114, 1860-1867.
- Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of Ocular Complications of AIDS Research Group (2007). Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular diagnoses at enrollment. Ophthalmology, 114, 780-786.
- Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, for the Studies of Ocular Complications of AIDS Research Group (2007). Longitudinal Study of the Ocular Complications of AIDS. 2. Ocular examination results at enrollment. Ophthalmology, 114, 787-793.
- Diabetic Retinopathy Clinical Research Network (2006). Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol, 124(12), 1701-7.
- Hartnett ME, Martiniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm JR (2006). Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 47(11), 4975-82.
- Geisen P, McColm JR, King BM, Hartnett ME (2006). Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture. Curr Eye Res, 31(9), 739-48.
- Balasubramanian M, Capone A Jr, Hartnett ME, Pignatto S, Trese MT (2006). The Photographic Screening for Retinopathy of Prematurity Study (Photo-ROP): study design and baseline characteristics of enrolled patients. Retina, 26(7 Suppl), S4-10.
- Hartnett ME, McColm JR (2006). Fibrovascular organization in the vitreous following laser for ROP: implications for prognosis. Retina, 26(7 Suppl), S24-31.
- McColm JR, Geisen P, Peterson LJ, Hartnett ME (2006). Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis. Exp Eye Res, 83(2), 438-46.
- Escaravage GK Jr, Cohen KL, Patel SB, Hartnett ME, Armstrong BD, Janowski CM (2006). Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus. J Cataract Refract Surg, 32(5), 803-11.
- Geisen P, McColm JR, Hartnett ME (2006). Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor. Exp Eye Res, 82(4), 608-19.
- PKC-DRS2 Group PI for LSU site (2006). Effect of Ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology, 113, 2221-2230.
- Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, for the Studies of Ocular Complications of AIDS Research Group (2006). Causes of Visual Acuity Loss Among Patients with AIDS and Cytomegalovirus in the Era of Highly Active Antiretroviral Therapy. Ophthalmology, 113, 1441-1445.
- Kempen JH, Min Y-I, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA for the Studies of Ocular Complications of AIDS Research Group (2006). Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology, 113, 684-694.
- Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB (2005). Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol, 123(3), 387-91.
- Hartnett ME, Maguluri S, Thompson HW, McColm JR (2004). Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina, 24(5), 753-7.
- McColm JR, Geisen P, Hartnett ME (2004). VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis, 10, 512-20.
- Van Cott EM, Laposata M, Hartnett ME (2004). Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis. Blood Coagul Fibrinolysis, 15(5), 393-7.
- Hartnett ME, McColm JR (2004). Retinal features predictive of progressive stage 4 retinopathy of prematurity. Retina, 24(2), 237-41.
- Jacobson MA, Maecker HT, Orr PL, DAmico R, Van Natta M, Li XD Pollard RB, Bredt BM for the Adult AIDS Clinical Trials Group and the Studies of Ocular Complications of AIDS Research Group (2004). Results of a CMV-specific CD8+/IFNy+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in AIDS patients with CMV retinitis. J Infect Dis, 189, 1362-1373.
- Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK for the Studies of Ocular Complications of AIDS Research Group (2004). Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology, 111, 2232-2239.
- Marshall BC, Jacobson MA, Adler SP in collaboration with the Studies of Ocular Complications of AIDS Research Group (2004). Avidity of antibodies to cytomegalovirus in HIV-seropositive patients with and without CMV retinitis. Viral Immunol, 17, 101-108.
- Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, DAmore PA (2003). Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res, 77(5), 593-9.
- Maguluri S, Hartnett ME (2003). Radial choroidal ruptures in sclopetaria. J Am Coll Surg, 197(4), 689-90.
- Hartnett ME, Rodier DW, McColm JR, Thompson HW (2003). Long-term vision results measured with Teller Acuity Cards and a new Light Perception/Projection Scale after management of late stages of retinopathy of prematurity. Arch Ophthalmol, 121(7), 991-6.
- Hartnett ME (2003). Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity. Retina, 23(3), 322-9.
- Hartnett ME, Laposata M, Van Cott E (2003). Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol, 135(4), 542-4.
- Kempen JH, Martin BK, Wu A, Barron B, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Group (2003). The effect of cytomegalovirus retinitis on the quality of life of patients with acquired immune deficiency syndrome in the era of highly active anti-retroviral therapy. Ophthalmology, 110, 987-995.
- Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D for the Studies of Ocular Complications of AIDS Research Group (2003). Visual loss in patients with cytomegalovirus retinitis and AIDS before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol, 121(1), 99-107.
- Miura M, Elsner AE, Beausencourt E, Kunze C, Hartnett ME, Lashkari K, Trempe CL (2002). Grading of infrared confocal scanning laser tomography and video displays of digitized color slides in exudative age-related macular degeneration. Retina, 22(3), 300-8.
- Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D (2000). Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care, 23(2), 234-40.
- Beausencourt E, Remky A, Elsner AE, Hartnett ME, Trempe CL (2000). Infrared scanning laser tomography of macular cysts. Ophthalmology, 107(2), 375-85.
- The STOP-ROP Multicenter Study Group (2000). Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A randomized, controlled trial. I: Primary Outcomes. Pediatrics, 105, 295-310.
- Andrews AP, Hartnett ME, Hirose T (1999). Surgical advances in retinopathy of prematurity. Int Ophthalmol Clin, 39(1), 275-90.
- Sheindlin JA, Hirose T, Hartnett ME (1999). Ophthalmic endoscopy: applications in intraocular surgery. Int Ophthalmol Clin, 39(1), 237-47.
- Remky A, Beausencourt E, Hartnett ME, Trempe CL, Arend O, Elsner AE (1999). Infrared imaging of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol, 237(11), 897-901.
- Hartnett ME, Garcia CM, DAmore PA (1999). Release of bFGF, an endothelial cell survival factor, by osmotic shock. Invest Ophthalmol Vis Sci, 40(12), 2945-51.
- Kunze C, Elsner AE, Beausencourt E, Moraes L, Hartnett ME, Trempe CL (1999). Spatial extent of pigment epithelial detachments in age-related macular degeneration. Ophthalmology, 106(9), 1830-40.
- Hartnett ME, Hirose T (1998). Cyanoacrylate glue in the repair of retinal detachment associated with posterior retinal breaks in infants and children. Retina, 18(2), 125-9.
- Armstrong D, Ueda T, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, Dandona P, Sasisekharan R, Dorey CK (1998). Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis, 2(1), 93-104.
- Beausencourt E, Elsner AE, Hartnett ME, Trempe CL (1997). Quantitative analysis of macular holes with scanning laser tomography. Ophthalmology, 104(12), 2018-29.
- Armstrong D, Ueda To, Ueda Ta, Browne R, Al-Jada A, Spengler R, Chou R, Fukuda S, Buch P, Dandona P, Hartnett ME, Sasisekharan R, Dorey KC (1997). Expression of TNF-alpha and VEGF during retinal neovascularization is initiated by lipid hydroperoxide. Angiogenesis, 2, 174-84.
- Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE (1996). Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology, 103(12), 2042-53.
- Steidl SM, Hirose T, Sang D, Hartnett ME (1996). Difficulties in excluding the diagnosis of retinoblastoma in cases of advanced Coats' disease: a clinicopathologic report. Ophthalmologica, 210(6), 336-40.
- Hartnett ME, Elsner AE (1996). Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology, 103(1), 58-71.
- Steidl S, Hirose T, Hartnett ME (1995). Open-sky vitrectomy for posterior segment reconstruction in eyes with severe trauma. Int Ophthalmol Clin, 35(1), 175-80.
- Hartnett ME, Pruett RC, DaSilva KC, Burkart PT (1994). Antiphospholipid antibody syndrome associated with microscotomata. Am J Ophthalmol, 118(3), 397-8.
- Hartnett ME, Katsumi O, Hirose T, Richardson TM, Walton DS (1994). Improved visual function in retinopathy of prematurity after lowering high intraocular pressure. Am J Ophthalmol, 117(1), 113-5.
- Hartnett ME, Coles WH (1993). Lens clarity after vitrectomy in traumatic lens perforation and vitreous penetration. Am J Ophthalmol, 116(2), 250-1.
- Hartnett ME, Gilbert MM, Hirose T, Richardson TM, Katsumi O (1993). Glaucoma as a cause of poor vision in severe retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol, 231(8), 433-8.
- Hartnett ME, Hirose T, Richardson TM, Garsd A, Gilbert MM, Krug J Jr (1992). Intraocular pressure determination in infants with severe retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol, 230(5), 406-10.
- Hartnett ME, Weiter JJ, Garsd A, Jalkh AE (1992). Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol, 230(1), 11-9.
- Hartnett ME, Gilbert MM, Richardson TM, Krug JH Jr, Hirose T (1990). Anterior segment evaluation of infants with retinopathy of prematurity. Ophthalmology, 97(1), 122-30.
- Lazarus HM, Hartnett ME, Reed MD, Murphy BF, Lass JH (1987). Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis. Am J Ophthalmol, 104(5), 476-80.
- Mangan KF, Hartnett ME, Matis SA, Winkelstein A, Abo T (1984). Natural killer cells suppress human erythroid stem cell proliferation in vitro. Blood, 63(2), 260-9.
- Krohel GB, Tobin DR, Hartnett ME, Barrows NA (1982). Divergence paralysis. Am J Ophthalmol, 94(4), 506-10.
Edited Book
- Hartnett ME, ed-in-chief (Eds.) (2005). Pediatric Retina. Philadelphia, PA: Lippincott Williams & Wilkins.
- Steidl S, Hartnett ME (Eds.) (2003). Clinical Pathways in Vitreoretinal Disease. New York, NY: Thieme Publishers.
- Schepens CL, Hartnett ME, Hirose T (Eds.) (2000). Schepens’ Retinal Detachment and Allied Diseases. (2nd edition). Boston, MA: Butterworth-Heinemann.